Lymph Node Yield at Radical Cystectomy Predicts Mortality in Node-negative and not Node-positive Patients
Todd M. Morgan(University of Michigan), Michael S. Cookson(University of Oklahoma Health Sciences Center), Shenghua Ni(Vanderbilt University), Peter E. Clark(Levine Cancer Institute), Sam S. Chang(Memorial Sloan Kettering Cancer Center), David F. Penson(Geriatric Research Education and Clinical Center), Joseph A. Smith(King's College London), Daniel A. Barocas(Vanderbilt University Medical Center)
Cited by 51
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845